The Medical University of South Carolina’s (MUSC) Zucker Institute for Applied Neuroscience and the MUSC Foundation for Research Development have announced they will be joining forces and will begin collectively doing business as the “Zucker Institute for Innovation Commercialization” (ZI) effective immediately.
The new combined institute solidifies MUSC’s commercialization efforts into a single more powerful engine with an increased ability to execute on its mission of facilitating the creation of new products and services that improve lives.
“The reorganization of the teams into the unified Zucker Institute for Innovation Commercialization positions the organization for growth and scale,” said Jesse Goodwin, Chief Innovation Officer at MUSC, who will chair the board of directors for ZI. “This new institute will continue to support the endeavors of MUSC’s inventive employees and students, such that their ideas become products and services generating meaningful impact.”
The reorganization creates a new technology transfer group that will act as a component of the Office of Innovation at MUSC as it looks to continue to build a culture of innovation around the enterprise that is nationally recognized. The group will be tasked with translating MUSC’s intellectual property-backed scholarly research, clinical and education efforts into products used beyond MUSC.